Tiotropium Bromide

噻托溴铵

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameTiotropium Bromide
Drug Alias Name噻托溴胺Tiotropii bromidum噻托溴铵一水合物Bromuro de tiotropioBromure de tiotropium +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveBronchial Spasm +[6] 
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Approved Indications in ChinaPulmonary Disease, Chronic Obstructive
Original Approved Country/TerritoryNetherlands
Original Approved Date2001/10/09
Country/TerritoryCzechiaBelgiumBulgaria +[58] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim Pharma Gmbh & Co KgPfizer Inc +[7] 
Inactive CompaniesPulmatrix IncNephron Pharmaceuticals CoSolventum US LLC +[8] 
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma
Inactive IndicationsLung Diseases, ObstructiveCystic FibrosisBronchitis, Chronic

Other Information

ATC CodeR03BB04
Related LinksWikipediaDrugBankKEGG